Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Irinotecan-induced colitis.

D Sandmeier1, P Chaubert, H Bouzourene

  • 1Institute of Pathology, Lausanne, Switzerland.

International Journal of Surgical Pathology
|May 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL-22-induced antimicrobial peptides are key determinants of mucosal vaccine-induced protection against H. pylori in mice.

Mucosal immunology·2016
Same author

Combination of immunohistochemistry and ploidy analysis to assist histopathological diagnosis of molar diseases.

Clinical medicine. Pathology·2011
Same author

Low dose endoluminal photodynamic therapy improves murine T cell-mediated colitis.

Endoscopy·2011
Same author

Detection of metastatic disease with sentinel lymph node dissection in colorectal carcinoma patients.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2007
Same author

A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene.

Familial cancer·2006
Same author

Mixed testicular germ cell tumor presenting as metastatic pure choriocarcinoma involving the maxillary gingiva.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·2006

Irinotecan, a chemotherapy drug, can cause delayed diarrhea. This case study documents colitis linked to Irinotecan in a glioblastoma patient, highlighting an unknown mechanism of this severe gastrointestinal toxicity.

Area of Science:

  • Oncology
  • Gastroenterology
  • Pharmacology

Background:

  • Irinotecan (CPT-11) is a topoisomerase I inhibitor used in chemotherapy.
  • Its major toxicities include myelosuppression and gastrointestinal (GI) issues, particularly delayed-onset diarrhea.
  • Serious GI side effects are reported in only 3% of cases, with an unknown mechanism for delayed diarrhea.

Observation:

  • This report details the first documented case of colitis associated with Irinotecan treatment for temporal glioblastoma.
  • The colitis was confirmed through histopathologic examination via biopsies.
  • The patient experienced delayed-onset diarrhea, a known but unpredictable side effect.

Findings:

  • Histopathologic findings of colitis in the context of Irinotecan therapy are presented.

Related Experiment Videos

  • The study discusses potential mechanisms underlying Irinotecan-induced colitis.
  • This case highlights a rare but severe gastrointestinal complication of Irinotecan therapy.

    • Implications:

    • Understanding the mechanisms of Irinotecan-induced colitis can improve patient management.
    • This case contributes to the literature on rare Irinotecan toxicities.
    • Further research is needed to elucidate the unpredictable GI side effects of Irinotecan.